ArticleeLife2018
Open access · goldAbstract read
In one paragraph
Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.
0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 77 citations in OpenAlex.
- Review
- Choosing the right animal model for sarcoma research.Cellular and molecular life sciences : CMLS · 2026Review
- Design principles of gene circuits for longevity.Trends in cell biology · 2025Review
- Article
- Genomic landscape and preclinical models of angiosarcoma.Molecular oncology · 2025Review
- Mcm5 mutation leads to silencing of Stat1-bcl2 which accelerating apoptosis of immature T lymphocytes with DNA damage.Cell death & disease · 2025Article
- Laboratory and physiological aspects of substitute metazoan models for in vivo pharmacotoxicological analysis.Naunyn-Schmiedeberg's archives of pharmacology · 2025Review
- A syngeneic spontaneous zebrafish model ofeLife · 2024Article
- miR-34a is a tumor suppressor in zebrafish and its expression levels impact metabolism, hematopoiesis and DNA damage.PLoS genetics · 2024Article
- Myogenesis gone awry: the role of developmental pathways in rhabdomyosarcoma.Frontiers in cell and developmental biology · 2024Review
- Zebrafish as a model system for studying reproductive diseases.Frontiers in cell and developmental biology · 2024Review
- Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies.Cancers · 2023Review
- Post-transcriptional checkpoints in autoimmunity.Nature reviews. Rheumatology · 2023Review
- Article
- Zebrafish-based platform for emerging bio-contaminants and virus inactivation research.The Science of the total environment · 2023Review
- Atm deficient zebrafish model reveals conservation of the tumour suppressor function and a role in fertility.Genes & diseases · 2023Article
- Review
- VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis.Cell reports · 2023Article
- Disruption of tp53 leads to cutaneous nevus and melanoma formation in Xenopus tropicalis.Molecular oncology · 2022Article
- Rbbp4 loss disrupts neural progenitor cell cycle regulation independent of Rb and leads to Tp53 acetylation and apoptosis.Developmental dynamics : an official publication of the American Association of Anatomists · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 4 institutions in 2 countries.
Myron S Ignatius *Department of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.
Madeline N Hayes *Department of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.
Finola E MooreDepartment of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.
Qin TangDepartment of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.ORCID 0000-0002-9487-570X
Sara P GarciaDepartment of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.
Patrick R BlackburnDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States.ORCID 0000-0003-0658-1275
Kunal BaxiDepartment of Molecular Medicine, Greehey Children's Cancer Research Institute, San Antonio, Texas.
Long WangDepartment of Molecular Medicine, Greehey Children's Cancer Research Institute, San Antonio, Texas.
Alexander JinDepartment of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.
Ashwin RamakrishnanDepartment of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.
Sophia ReederDepartment of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.
Yidong ChenDepartment of Molecular Medicine, Greehey Children's Cancer Research Institute, San Antonio, Texas.
Gunnlaugur Petur NielsenDepartment of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.
Eleanor Y ChenDepartment of Pathology, University of Washington, Seattle, United States.
Robert P HasserjianDepartment of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.
Franck TirodeDepartment of Translational Research and Innovation, Université Claude Bernard Lyon, Cancer Research Center of Lyon, Lyon, France.ORCID 0000-0003-4731-7817
Stephen C EkkerDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, United States.ORCID 0000-0003-0726-4212
David M LangenauDepartment of Pathology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.ORCID 0000-0001-6664-8318
Massachusetts General Hospital · USMayo Clinic · USUniversité Claude Bernard Lyon 1 · FRUniversity of Washington · US
Funding
MAYO CLINIC CENTER FOR TRANSLATIONAL SCIENCE ACTIVITIESUL1RR024150 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 2006 to 2011
$66.4MTissue and Pathology ResourcesU54CA168512 · NCI · SARC · PI CROWLEY, JOHN J · 2012 to 2016
$11.0MSystematic Vertebrate Functional GenomicsR01GM063904 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI EKKER, STEPHEN CARL · 2001 to 2025
$10.7MImmune Compromises Zebrafish for Cell TransplantationR24OD016761 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI LANGENAU, DAVID MICHAEL · 2013 to 2021
$5.2MGenetics of RhabdomyosarcomaR01CA154923 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI LANGENAU, DAVID MICHAEL · 2011 to 2021
$3.8MCancer Biology Training ProgramT32CA148724 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Pei Wang, Feng-Chun Yang · 2011 to 2026
$3.3MOncogenic pathways and therapeutic targets in T cell acute lymphoblastic leukemiaR01CA211734 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI LANGENAU, DAVID MICHAEL · 2017 to 2021
$1.9MStem cell self-renewal programs in rhabdomyosarcomaR01CA215118 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI LANGENAU, DAVID MICHAEL · 2018 to 2022
$1.9MA role for notch in self renewal in embryonal rhabdomyosarcomaR00CA175184 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI IGNATIUS, MYRON STEVE · 2017 to 2019
$747kMassachusetts General Hospital Research Scholars ProgramNational Cancer Center R01CA211734National Cancer Center R01CA215118National Cancer Center RR160062NCI NIH HHS GM63904NCI NIH HHS R00 CA175184NCI NIH HHS R00CA175184NCI NIH HHS R01 CA154923NCI NIH HHS R01CA154923NCI NIH HHS R01 CA211734NCI NIH HHS R01 CA215118NCI NIH HHS R24OD016761NCI NIH HHS T32 CA148724NCI NIH HHS U54CA168512NCI NIH HHS UL1RR024150NCRR NIH HHS UL1 RR024150NIGMS NIH HHS R01 GM063904NIH HHS R24 OD016761Rally Foundation Amanda Riley Foundation Research Fellowship
Abstract
The
Indexed as
AnimalsCell CountGene DeletionGene Expression Regulation, NeoplasticHemangiosarcomaHomozygoteLeukemiaNeoplasm InvasivenessNeoplasm MetastasisNeoplasms, Germ Cell and EmbryonalNeoplasm TransplantationNeoplastic Stem CellsRhabdomyosarcoma, EmbryonalSurvival AnalysisTumor Suppressor Protein p53ZebrafishTumor Suppressor Protein p53angiosarcomacancer biologygerm cell tumorleukemiametastasisMPNSTrhabdomyosarcomazebrafish
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.